Burcon Granted Second U.S. CLARISOY Patent

Burcon Granted Second U.S. CLARISOY Patent

VANCOUVER, British Columbia, April 4, 2013 (GLOBE NEWSWIRE) -- Burcon
NutraScience Corporation (TSX:BU) (Nasdaq:BUR), a leader in functional,
renewable plant proteins, has been awarded U.S. patent No. 8,404,299 for a
patent covering a process for the production of CLARISOY™ soy protein that is
soluble in an acidic medium, and produces transparent, heat stable solutions
suitable for protein fortification of sports drinks and other beverages.

This marks the second U.S. CLARISOY patent awarded to Burcon in the last two
months.The previously announced notice ofallowance has also now officially
been granted as U.S. Patent No. 8,389,040.

"We are encouraged to have a second U.S. patent grant so soon after obtaining
our first," said Johann F. Tergesen, Burcon's president and COO."Our patent
strategy is being rewarded with positive results, strengthening our already
broad intellectual property portfolio. CLARISOY soy protein is the world's
only plant-based protein capable of offering both clarity and high-quality
protein nutrition in low pH beverages, like sports drinks and juices.
CLARISOY's unique functional and nutritional attributes are what drive its
strong commercial value."

Burcon's patent portfolio now consists of 224 issued patents in various
countries,including 38 in the U.S., as well as more than 400 active patent
applications,including 81 additional U.S. patent applications.

About CLARISOY Soy Protein

CLARISOY soy protein is the world's only vegetable-based protein capable of
offering both clarity and high-quality protein nutrition in low pH beverage
systems.

CLARISOY is currently under license to ADM, which offers a range of products
for both low and neutral pH applications, allowing food and beverage companies
to easily include up to 10 grams of CLARISOY per 500mL serving.

CLARISOY 100 is a premier vegetable-based protein that offers both clarity and
high-quality protein nutrition for beverages with a pH of less than 4.
Extremely heat stable, CLARISOY 100 requires no homogenization or stabilizers
in low pH beverages.

CLARISOY 150 is a revolutionary soy protein for neutral pH beverages and low
pH beverages with cloud systems. The clean flavor and smooth mouth-feel makes
CLARISOY 150 a formulator's ideal protein ingredient.

For more information about CLARISOY, visitwww.clarisoy.com 

About Burcon NutraScience Corporation

Burcon NutraScience is a leader in nutrition, health and wellness in the field
of functional plant proteins. The company has developed a portfolio of
composition, application, and process patents originating from a core protein
extraction and purification technology. Burcon has developed: CLARISOY™ soy
protein - now licensed to Archer Daniels Midland Company - which offers
clarity and high-quality protein nutrition for low pH beverage systems and
exceptionally clean flavor at any pH; Peazazz™ a uniquely soluble and
clean-tasting pea protein; and Puratein®, Supertein™ and Nutratein™ are canola
protein isolates with unique functional and nutritional attributes. For more
information about the company, visitwww.burcon.ca

The TSX has not reviewed and does not accept responsibility for the adequacy
of the content of the information contained herein. This press release
contains forward-looking statements or forward-looking information.
Forward-looking statements or forward-looking information involve risks,
uncertainties and other factors that could cause actual results, performances,
prospects and opportunities to differ materially from those expressed or
implied by such forward-looking statements. All statements other than
statements of historical fact included in this release are forward-looking
statements, including, without limitation, statements regarding plans and
timing for the introduction or enhancement of our products, statements about
future market conditions, supply and demand conditions, and other
expectations, intentions and plans contained in this press release. There can
be no assurance that such statements will prove to be accurate and actual
results and future events could differ materially from those anticipated in
such statements or information. Important factors that could cause actual
results to differ materially from Burcon's plans and expectations include the
actual results of marketing activities, adverse general economic, market or
business conditions, regulatory changes and other risks and factors detailed
herein and from time to time in the filings made by Burcon with securities
regulators and stock exchanges, including in the section entitled "Risk
Factors" in Burcon's annual information form dated June 25, 2012. Any
forward-looking statement or information only speaks as of the date on which
it was made and, except as may be required by applicable securities laws,
Burcon disclaims any intent or obligation to update any forward-looking
statement, whether as a result of new information, future events or otherwise.
Although Burcon believes that the assumptions inherent in the forward-looking
statements are reasonable, forward-looking statements are not guarantees of
future performance and accordingly undue reliance should not be put on such.

CONTACT: Media & Industry Contact:
         Michael Kirwan
         Director, Corporate Development
         Burcon NutraScience Corporation
         (604) 733-0896
         (888) 408-7960 toll-free
         mkirwan@burcon.ca www.burcon.ca
        
         Investor Relations Contact:
         John MacLennan
         Managing Director
         Tel (416) 644.8688
         john@liolios.com
 
Press spacebar to pause and continue. Press esc to stop.